Ipca Laboratories Ltd. (IPCALAB): Ipca Laboratories Share Price rises 2.57% as stock gains today
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Ipca Laboratories Share Price moved higher today, with the stock rising 2.57% to Rs 2,020.40, up Rs 50.60 from the previous close of Rs 1,969.80. The company’s market capitalisation stood at Rs 49,468.52 crore, placing the move in a sizeable listed healthcare name on the Indian market. The available data confirms the price event and turnover, but it does not establish a company-specific catalyst. For readers tracking Ipca Laboratories Share Price Today, the session is relevant because the move came alongside a day high of Rs 2,025 and a day low of Rs 1,964.50, which frames the range of trade during the session.
For anyone following Ipca Laboratories Stock News, the verified facts point to a same-day share price rise rather than a fresh business disclosure. Univest is tracking the move through a stock-market lens that combines price action, valuation and sector context. That makes Ipca Laboratories Share Price a useful event to watch in the broader Healthcare and Pharmaceuticals & Drugs space, even as the data set stops short of assigning a trigger.
Ipca Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,020.4 |
| Previous Close | Rs 1,969.8 |
| Today's Move | Rs 50.6 (+2.57%) |
| Open | Rs 1,975.65 |
| High | Rs 2,025 |
| Low | Rs 1,964.5 |
| Turnover | Rs 7.74 crore |
| Market Capitalisation | Rs 49,468.52 crore |
| Market Cap Category | Large Cap |
Ipca Laboratories Ltd. (IPCALAB) rose to Rs 2,020.4 from the previous close of Rs 1,969.8, a move of Rs 50.6 or 2.57%. The stock opened at Rs 1,975.65, reached a high of Rs 2,025, recorded a low of Rs 1,964.5.
Ipca Laboratories Share Price Today closed the session at Rs 2,020.40 after opening at Rs 1,975.65, touching a high of Rs 2,025 and a low of Rs 1,964.50. The stock added Rs 50.60, or 2.57%, versus the previous close of Rs 1,969.80. Turnover for the day stood at Rs 7.74 crore. The available numbers confirm a positive price rise, while the event data itself does not identify a company-specific reason. For Ipca Laboratories Share Price news readers, the key takeaway is straightforward: the stock gained in today’s trade and remained within a relatively narrow intraday band around the final quote. Univest presents this as a verified market move rather than a story built on speculation.
Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,468.52 crore |
| P/E Ratio | 38.15x |
| P/B Ratio | 5.89x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.3% |
Ipca Laboratories Ltd. (IPCALAB) fundamental metrics show P/E 38.15x, P/B 5.89x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.
Ipca Laboratories Ltd. has a market capitalisation of Rs 49468.52 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.15x, P/B at 5.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 51.63, book value per share of Rs 334.38, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.15x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 5.89x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 49,468.52 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.15x, which is above the benchmark median of 32.69x, a difference of +16.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ipca Laboratories Ltd. (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.78%, a difference of +34.8%. Ipca Laboratories Ltd. (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.65%, a difference of +42.2%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Ipca Laboratories Ltd. (IPCALAB) has a P/E ratio of 38.15x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.88% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 49,468.52 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price rose 2.57% today to Rs 2,020.40, versus a previous close of Rs 1,969.80.
- The session ranged between Rs 1,964.50 and Rs 2,025, with turnover of Rs 7.74 crore.
- Market capitalisation stood at Rs 49,468.52 crore, which frames the company’s current scale.
- P/E is 38.15, P/B is 5.89, ROE is 15.88% and ROCE is 19.41%, giving valuation and return context.
- In the same-industry benchmark, the company’s ROE and ROCE are above the median and average values supplied.
About Ipca Laboratories
Ipca Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by investors for its operating profile, valuation and place in the listed pharma universe. In the current data set, Ipca Laboratories Share Price is supported by a business backdrop that can be read through earnings and return measures rather than through any single event headline. The company’s EPS of Rs 51.63 suggests the earnings attributed to each share, while book value of Rs 334.38 per share reflects the accounting net worth behind each share. Dividend yield of 0.3% gives a current income reference point. On Univest, this company overview sits alongside price action, ratios and peer comparisons so readers can place today’s move in a broader financial context.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Ipca Laboratories Share Price on Univest for live price updates, company news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest brings together Ipca Laboratories Share Price Today data, sector context and peer comparison in one place, helping readers follow the stock’s movement without relying on scattered sources. For those monitoring Ipca Laboratories Stock News or Ipca Laboratories Latest News, the platform keeps the focus on verified numbers and structured analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Ipca Laboratories Share Price rising today?
Ans. Ipca Laboratories Share Price rose 2.57% to Rs 2,020.40 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst or news trigger for the move.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price today is Rs 2,020.40. It was up Rs 50.60 from the previous close of Rs 1,969.80, with intraday trade between Rs 1,964.50 and Rs 2,025. The previous close was Rs 1,969.8.
What is the market capitalisation of Ipca Laboratories?
Ans. Ipca Laboratories has a market capitalisation of Rs 49,468.52 crore. That figure shows the company’s scale in the listed market and helps frame today’s share price rise in context. The company operates in the Healthcare sector.
How do Ipca Laboratories valuation ratios look today?
Ans. Ipca Laboratories is valued at a P/E of 38.15 and a P/B of 5.89. EPS is Rs 51.63 and book value is Rs 334.38, offering context for the stock’s current pricing.
How does Ipca Laboratories compare with sector benchmarks?
Ans. In the same-industry benchmark, Ipca Laboratories’ P/E of 38.15 is above the median of 32.69, while its ROE of 15.88% and ROCE of 19.41% are above both benchmark medians. The stock belongs to the Healthcare sector.
How does Ipca Laboratories compare with peers?
Ans. Ipca Laboratories’ P/E of 38.15 sits above Cipla and Sun Pharma, but below Divi’s and Torrent Pharma. Its market cap is smaller than those peers, while ROE and ROCE stay competitive.
What does Ipca Laboratories dividend yield show?
Ans. Ipca Laboratories has a dividend yield of 0.3%. Dividend yield is a current income reference point, and it should be read alongside EPS, book value and valuation ratios rather than in isolation.
